Meropenem Aptapharma

Meropenem, the active ingredient in Meropenem Aptapharma, is a carbapenem antibiotic presented as an intravenous solution for intravenous use. It treats severe bacterial infections such as intra‑abdominal infections, urinary tract infections, pneumonia, meningitis, and sepsis in hospitalized patients.

GNH USA supplies Meropenem Aptapharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Meropenem is a broad‑spectrum carbapenem used to treat serious bacterial infections in the hospital setting. - Complicated intra‑abdominal infections: provides bacterial eradication in severe abdominal infections. - Complicated urinary tract infections: eliminates resistant uropathogens causing kidney and bladder infections. - Nosocomial pneumonia: treats hospital‑acquired lung infections resistant to other antibiotics. - Meningitis: penetrates the cerebrospinal fluid to combat bacterial meningitis. - Severe sepsis and septic shock: offers rapid bactericidal activity in life‑threatening systemic infections.

Meropenem may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: may be watery and self‑limiting. - Headache: transient cranial discomfort. - Rash: erythematous skin eruption. - Elevated liver enzymes: transient increase in ALT/AST. - Infusion site reactions: erythema or phlebitis at the IV site.

Serious or Rare Side Effects: - Seizures: especially in patients with renal impairment. - Anaphylaxis: acute, potentially life‑threatening hypersensitivity. - Clostridioides difficile infection: severe colitis risk. - Severe neutropenia: marked reduction in white blood cells. - Renal toxicity: impaired kidney function. - Hypersensitivity reactions: including Stevens‑Johnson syndrome.

Use meropenem with caution, observing clinical guidelines and patient-specific factors. - Renal function: adjust dose in patients with impaired kidney function. - Neurological status: monitor for seizures, particularly in those with CNS disorders. - Hepatic function: assess liver enzymes before and during therapy. - Allergies: avoid in patients with known carbapenem or β‑lactam hypersensitivity. - Concomitant nephrotoxic drugs: monitor renal parameters closely. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Meropenem can interact with several medications, requiring vigilance.

Major Interactions (Avoid): - Valproic acid: carbapenems reduce serum valproate levels, increasing seizure risk. - Probenecid: may increase meropenem plasma concentrations, raising toxicity potential. - Rifampicin: can lower meropenem levels, reducing efficacy.

Moderate Interactions (Monitor Closely): - Loop diuretics: combined use may exacerbate renal impairment. - Aminoglycosides: additive nephrotoxicity; monitor kidney function. - Anticoagulants (e.g., warfarin): may alter INR; check coagulation status regularly.